Paris, France

Pablo Guardado-Calvo

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Pablo Guardado-Calvo in Dengue Virus Research

Introduction

Pablo Guardado-Calvo is a notable inventor based in Paris, France. He has made significant contributions to the field of virology, particularly in the development of anti-dengue vaccines and antibodies. His innovative work has led to the filing of two patents that focus on the Dengue virus Envelope Dimer Epitope (EDE).

Latest Patents

Guardado-Calvo's latest patents include groundbreaking research on anti-dengue vaccines and antibodies. The patents detail a Dengue virus Envelope Dimer Epitope (EDE) that spans the polypeptides of a Dengue virus Envelope polypeptide dimer. The EDE is presented on a dimer of Envelope proteins and is formed from consecutive or non-consecutive residues of the envelope polypeptide dimer. This dimer can be a homodimer or heterodimer of native and/or mutant envelope polypeptides from any one or two of DENV-1, DENV-2, DENV-3, and DENV-4. The EDE may also be a stabilized recombinant dengue virus envelope glycoprotein E ectodomain (sE) dimer, which is covalently stabilized with at least one disulphide inter-chain bond between the two sE monomers. Additionally, it can be stabilized through various methods, including sulfhydryl-reactive crosslinkers and modified sugars. The invention also includes compounds, such as antibodies or antibody fragments, that can neutralize more than one Dengue virus serotype.

Career Highlights

Throughout his career, Guardado-Calvo has worked with prestigious institutions, including Université Paris-Saclay and Imperial College Innovations Limited. His research has been pivotal in advancing the understanding of dengue virus and developing effective vaccines.

Collaborations

Some of his notable coworkers include Juthathip Mongkolsapaya and Alexander Rouvinski. Their collaborative efforts have contributed to the success of his research initiatives.

Conclusion

Pablo Guardado-Calvo's innovative work in the field of dengue virus research has led to significant advancements in vaccine development. His contributions are vital in the ongoing fight against dengue fever, showcasing the importance of research and innovation in public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…